Cooley advised SiTime Corporation, while Davis Polk advised the sales agent, Stifel, Nicolaus & Company, in the offering. SiTime Corporation issued an SEC-registered at-the-market offering consisting of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Acutus Medical on the deal. Acutus Medical, Inc. announced the sale of its left-heart access portfolio products to Medtronic, for an upfront payment of...
You must be a Standard 1 Year member to access this content.
Cooley advised AN2 Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering. AN2 Therapeutics, Inc. announced its upsized initial public offering of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. Adagio Therapeutics, Inc. executed the initial public offering of 20,930,000 shares of its common stock at...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. RxSight, Inc. executed an initial public offering of 7,350,000 shares of common stock at $16.00 per...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering while Wilson Sonsini Goodrich & Rosati represented Tenaya Therapeutics. Tenaya Therapeutics, Inc. executed the initial...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Sight Sciences, Inc. in the offering, while Davis Polk advised the representatives of the several underwriters. Sight Sciences, Inc. executed its initial public...
You must be a Standard 1 Year member to access this content.
